EXCLUSIVE: Bizarre symptom of thyroid CANCER that was dismissed for months
A woman suffered from a chronic cough for six months and underwent testing before doctors discovered she had an enlarged thyroid. After more tests, it was revealed she had thyroid cancer. (Source: the Mail online | Health)
Source: the Mail online | Health - November 13, 2023 Category: Consumer Health News Source Type: news
FDA Approves Zepbound, the Most Potent Weight Loss Drug Yet
Weight loss drugs have dominated the headlines over the past year, and now there’s a new medication that may be the most effective one yet.
On Nov. 11, the U.S. Food and Drug Administration (FDA) approved tirzepatide (which will be sold under the brand name Zepbound), to treat overweight and obesity. Made by Eli Lilly and Co., the drug is already approved, in different doses, for type 2 diabetes, as Mounjaro, and its effectiveness in those patients is due in part to its weight loss effects.
[time-brightcove not-tgx=”true”]
About 70% of Americans are overweight, with a body mass index (BMI) between ...
Source: TIME: Health - November 9, 2023 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized healthscienceclimate Source Type: news
Pervasive'Forever Chemicals' Linked to Thyroid Cancer? Pervasive'Forever Chemicals' Linked to Thyroid Cancer?
A small study suggests that environmental PFAS exposure may raise the risk for thyroid cancer. But a biostatistician who reviewed the findings is not convinced.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - November 7, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
Should We End Obesity?
It’s unusual for a medication to become a household name; even more uncommon for its branding to become, like Advil, shorthand for an entire class of products; and rarest of all, for it to change not just U.S. medicine, but U.S. culture.
Ozempic has done all three.
Approved in 2017 as a type 2 diabetes medication, Ozempic has largely made its name—and a fortune for its manufacturer, Novo Nordisk—as a weight-loss aid. Novo Nordisk knew early on that diabetes patients often lost weight on the drug, but even company executives couldn’t have guessed how widely it would eventually take off as both ...
Source: TIME: Health - November 7, 2023 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized Drugs feature healthscienceclimate Magazine TIME 2030 Wellbeing Source Type: news
This Modern Fad Is Making You Sick
The government declared war on fat almost 50 years ago. And as a result, we got slower, sicker, and fatter.
In fact, the results of this big fat lie “led to some pretty disastrous consequences…that caused Americans to get fatter.”
Those are the words of one of the most famous nutritionists in the world.
Dr. Walter Willett, Chair of the Department of Nutrition at the Harvard T.H. Chan School of Public Health, was one of the first mainstream physicians to admit that the campaign to eliminate fat in the diet was a big mistake.
But lately, he’s shifted gears. And today, he’s declared war on meat.
I couldn’t dis...
Source: Al Sears, MD Natural Remedies - November 3, 2023 Category: Complementary Medicine Authors: Jacob Tags: Health Nutrition Source Type: news
Ultrasound features tied to thyroid microcarcinoma tumor growth
Ultrasonic features are tied to an increased risk of tumor progression in patients with papillary thyroid microcarcinoma undergoing active surveillance, a South Korean study published October 31 in Radiology found.
Researchers led by Ji Ye Lee, MD, from Seoul National University Hospital found that ultrasound features of diffuse thyroid disease and intratumoral vascularity, along with other patient characteristics, are significantly associated with this thyroid cancer.
“Prediction incorporating ultrasound features may help personalize surveillance strategies in the future,” Lee and colleagues wrote.
Active surveilla...
Source: AuntMinnie.com Headlines - November 1, 2023 Category: Radiology Authors: Amerigo Allegretto Tags: Ultrasound Source Type: news
Intermittent Fasting for T2D; Omnipod 5 App Cleared; GLP-1 Meds and Thyroid Cancer
(MedPage Today) -- Intermittent fasting can help patients with type 2 diabetes lose weight and better control their glucose levels. (JAMA Network Open)
How far should doctors go to treat childhood obesity? (New York Times)
The FDA cleared the... (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - November 1, 2023 Category: Endocrinology Source Type: news
Wegovy and Thyroid Cancer; Maine Shooter's Mental Health; 469 Heat Deaths
(MedPage Today) -- Note that some links may require registration or subscription.
No causal connection exists between GLP-1 agonists such as semaglutide (Ozempic, Wegovy) and thyroid cancer, a safety panel for the European Medicines Agency concluded... (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - October 30, 2023 Category: Psychiatry Source Type: news
EU Agency Sees No Evidence New Weight Loss Drugs Cause Thyroid Cancer
(Source: Reuters: Health)
Source: Reuters: Health - October 27, 2023 Category: Consumer Health News Source Type: news
GLP-1s Like Semaglutide: Less Thyroid Cancer Than Insulin GLP-1s Like Semaglutide: Less Thyroid Cancer Than Insulin
Among people with type 2 diabetes who received a GLP-1 receptor agonist, there was less correlation between this treatment and thyroid cancer than among people with type 2 diabetes treated with insulin.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - October 25, 2023 Category: Drugs & Pharmacology Tags: Diabetes & Endocrinology News Source Type: news
PFAS 'forever chemicals' found in virtually every room in your home raise risk of fastest growing cancer in America by 56 PERCENT, study suggests
Researchers confirmed a link between thyroid cancer and hormone-disrupting forever chemicals found everywhere from frying pans to firefighting foam. (Source: the Mail online | Health)
Source: the Mail online | Health - October 24, 2023 Category: Consumer Health News Source Type: news
Exposure to PFAS Linked to Increased Rate of Thyroid Cancer
TUESDAY, Oct. 24, 2023 -- Exposure to per- and polyfluoroalkyl substances (PFAS) is associated with an increased rate of thyroid cancer, according to a study published online Oct. 24 in eBioMedicine.Maaike van Gerwen, M.D., Ph.D., from the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 24, 2023 Category: Pharmaceuticals Source Type: news
RET Inhibitor Posts Frontline Wins in Medullary Thyroid Cancer, NSCLC
(MedPage Today) -- MADRID -- First-line treatment with the RET inhibitor selpercatinib (Retevmo) achieved superior outcomes in both medullary thyroid cancer (MTC) and advanced non-small cell lung cancer (NSCLC), according to results from two... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - October 23, 2023 Category: Hematology Source Type: news
Phase 3 Trial of Selpercatinib in Advanced RET-Mutant Medullary Thyroid Cancer
(Source: Reuters: Health)
Source: Reuters: Health - October 21, 2023 Category: Consumer Health News Source Type: news
Scientists call on ministers to cut limits for ‘forever chemicals’ in UK tap water
Permitted levels of PFAS should be lowered tenfold and national chemicals agency created, says Royal Society of ChemistryAcceptable levels of “forever chemicals” in drinking water should be reduced tenfold and a new national chemicals agency created to protect public health, the Royal Society of Chemistry (RSC) has told the UK government.The chartered body wants to see a reduction in the cap on levels of per- and polyfluoroalkyl substances (PFAS) in tap water. PFAS are a family of about 10,000 widely used chemicals that do not break down easily in the environment. Some have been linked to cancers, liver and thyroid dis...
Source: Guardian Unlimited Science - October 18, 2023 Category: Science Authors: Rachel Salvidge and Leana Hosea Tags: PFAS Water Water industry Environment UK news Politics Source Type: news
